Assorted News from the Last Two Weeks: The Centers for Disease Control and Prevention updated its cancer cluster guidelines. “About 85% of children with cancer
Assorted News from the Last Week: FDA approves Brentuximab for high-risk Hodgkin Lymphoma in children and adolescents. The Comprehensive Cancer Survivorship Act was introduced to
Assorted News from the Last Week: For many patients, one of the most antagonizing parts of a hospital visit is paying for parking. Those parking fees
Assorted News from the Last Week: “I’d like to introduce you to Josh. . . Josh, a sound engineer, is also a childhood cancer survivor
Assorted News from the Last Week: CAC2 Member Mary Beth Collins explains the importance of the new FDA approval of Pedmark: “With the FDA’s recent
Assorted News from the Last Week: CAC2 Member Joe Baber reflects on the Gabriella Miller Kids First 2.0 legislation pending in Congress: “We’re all thankful
Assorted News from the Last Week: The FDA has approved brentuximab vedotin (Adcetris) in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide (AVE-PC) in pediatric
Assorted News from the Last Week: November is National Family Caregivers Month. The President Joe Biden honored family caregivers for all they do for the
Assorted News from the Last Week: CBS “Sunday Morning” contributor Kelefa Sanneh talked with CAC2 Members Kari and Tom Whitehead and their daughter Emily about
Assorted News from the Last Week: Nearly one in four families of pediatric patients with acute lymphoblastic leukemia (ALL) enrolled in a clinical trial experienced
